BioPlus Acquisition (BioPlus Acquisition) Inventory-to-Revenue : 0.00 (As of Jun. 2023)

---

BioPlus Acquisition Inventory-to-Revenue Chart

---

Competitive Comparison of BioPlus Acquisition's Inventory-to-Revenue

For the Shell Companies subindustry, BioPlus Acquisition's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

---

BioPlus Acquisition's Inventory-to-Revenue Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, BioPlus Acquisition's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where BioPlus Acquisition's Inventory-to-Revenue falls into.

---

BioPlus Acquisition Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

BioPlus Acquisition's Inventory-to-Revenue for the fiscal year that ended in Dec. 2022 is calculated as

BioPlus Acquisition's Inventory-to-Revenue for the quarter that ended in Jun. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

---

BioPlus Acquisition  (NAS:BIOS) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

BioPlus Acquisition's Days Inventory for the three months ended in Jun. 2023 is calculated as:

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

BioPlus Acquisition's Inventory Turnover for the quarter that ended in Jun. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

---

BioPlus Acquisition Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of BioPlus Acquisition's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Total Inventories Revenue Days Inventory Cost of Goods Sold Inventory Turnover

---

BioPlus Acquisition (BioPlus Acquisition) Business Description

Executives

Steven C. Fletcher	10 percent owner	C/O LEE ENTERPRISES, INCORPORATED, 4600 EAST 53RD STREET, DAVENPORT IA 52807
Explorer Parent Llc	10 percent owner	533 AIRPORT BOULEVARD, SUITE 400, BURLINGAME CA 94012
Founder Holdings Llc	10 percent owner	533 AIRPORT BOULEVARD, SUITE 400, BURLINGAME CA 94012
Alex Serge Vieux	10 percent owner	C/O COMPUTER ASSOCIATES INTER INC, ONE COMPUTER ASSOC PLAZA, ISLANDIA NY 11749
Bioplus Sponsor Llc	10 percent owner	544 AIRPORT BOULEVARD, SUITE 400, BURLINGAME CA 94010
Stephen A Sherwin	director	C/O CELL GENESYS, INC., 500 FORBES BLVD., SOUTH SAN FRANCISCO CA 94080
Louis G Lange	director	3172 PORTER DRIVE, PALO ALTO CA 94034
Ross Haghighat	director, officer: CEO and CFO	C/O ADURO BIOTECH, INC., 626 BANCROFT WAY, 3C, BERKELEY CA 94710
Ronald W Eastman	director	335 BRYANT STREET, THIRD FLOOR, PALO ALTO CA 94301
Shawn Cross	director	1825 K STREET SUITE 510, WASHINGTON DC 20006
Jonathan Rigby	director, officer: Chief Business Officer	ARADIGM CORPORATION, 3929 POINT EDEN WAY, HAYWARD CA 94545
Glen Giovannetti	director	UNIT 6706, THE CENTER, 99 QUEEN'S ROAD CENTRAL, HONG KONG K3 00000